These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 24535025)

  • 1. Dyslipidemia and progression of kidney disease: role of lipid-lowering drugs.
    Campese VM
    Clin Exp Nephrol; 2014 Apr; 18(2):291-5. PubMed ID: 24535025
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Statins in patients with kidney failure: efficacy, tolerance, and prescription guidelines in patients with chronic kidney disease and renal transplant].
    Karie S; Launay-Vacher V; Deray G; Isnard-Bagnis C
    Presse Med; 2006 Feb; 35(2 Pt 1):219-29. PubMed ID: 16493350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HMG CoA reductase inhibitors (statins) for preventing acute kidney injury after surgical procedures requiring cardiac bypass.
    Lewicki M; Ng I; Schneider AG
    Cochrane Database Syst Rev; 2015 Mar; 2015(3):CD010480. PubMed ID: 25758322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Considerations in the treatment of dyslipidemia associated with chronic kidney failure and renal transplantation.
    Davidson M
    Prev Cardiol; 2005; 8(4):244-9. PubMed ID: 16230879
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in LDL-C levels and goal attainment associated with addition of ezetimibe to simvastatin, atorvastatin, or rosuvastatin compared with titrating statin monotherapy.
    Foody JM; Toth PP; Tomassini JE; Sajjan S; Ramey DR; Neff D; Tershakovec AM; Hu H; Tunceli K
    Vasc Health Risk Manag; 2013; 9():719-27. PubMed ID: 24265554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative Effectiveness and Toxicity of Statins Among HIV-Infected Patients.
    Singh S; Willig JH; Mugavero MJ; Crane PK; Harrington RD; Knopp RH; Kosel BW; Saag MS; Kitahata MM; Crane HM
    Clin Infect Dis; 2011 Feb; 52(3):387-95. PubMed ID: 21189273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Statin wars: the heavyweight match--atorvastatin versus rosuvastatin for the treatment of atherosclerosis, heart failure, and chronic kidney disease.
    DiNicolantonio JJ; Lavie CJ; Serebruany VL; O'Keefe JH
    Postgrad Med; 2013 Jan; 125(1):7-16. PubMed ID: 23391667
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects on serum uric acid by difference of the renal protective effects with atorvastatin and rosuvastatin in chronic kidney disease patients.
    Kose E; An T; Kikkawa A; Matsumoto Y; Hayashi H
    Biol Pharm Bull; 2014; 37(2):226-31. PubMed ID: 24492719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Strong statins as the major players for dyslipidemia in high-risk patients: are they all the same or not?
    Ikewaki K; Ayaori M
    Circ J; 2011; 75(6):1326-7. PubMed ID: 21532174
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of three strong statins (atorvastatin, pitavastatin, and rosuvastatin) on serum uric acid levels in dyslipidemic patients.
    Ogata N; Fujimori S; Oka Y; Kaneko K
    Nucleosides Nucleotides Nucleic Acids; 2010 Jun; 29(4-6):321-4. PubMed ID: 20544514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. From CARDS to AURORA: one disease, two responses.
    Escobar C; Barrios V; Echarri R
    Hellenic J Cardiol; 2010; 51(3):281. PubMed ID: 20515865
    [No Abstract]   [Full Text] [Related]  

  • 12. Use of high potency statins and rates of admission for acute kidney injury: multicenter, retrospective observational analysis of administrative databases.
    Dormuth CR; Hemmelgarn BR; Paterson JM; James MT; Teare GF; Raymond CB; Lafrance JP; Levy A; Garg AX; Ernst P;
    BMJ; 2013 Mar; 346():f880. PubMed ID: 23511950
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized head-to-head comparison of pitavastatin, atorvastatin, and rosuvastatin for safety and efficacy (quantity and quality of LDL): the PATROL trial.
    Saku K; Zhang B; Noda K;
    Circ J; 2011; 75(6):1493-505. PubMed ID: 21498906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comment from the cardiologic viewpoint].
    Lüscher TF
    Praxis (Bern 1994); 2009 Feb; 98(3):129-30. PubMed ID: 19180438
    [No Abstract]   [Full Text] [Related]  

  • 15. Achievement rates of Japan Atherosclerosis Society Guidelines 2007 LDL-cholesterol goals with rosuvastatin or atorvastatin in patients who had not achieved their goal with atorvastatin.
    Shioji K; Izuhara M; Mitsuoka H; Uegaito T; Matsuda M;
    Cardiovasc Ther; 2014 Jun; 32(3):97-104. PubMed ID: 24456217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of dyslipidemia in statin-treated patients in Canada: results of the DYSlipidemia International Study (DYSIS).
    Goodman SG; Langer A; Bastien NR; McPherson R; Francis GA; Genest JJ; Leiter LA;
    Can J Cardiol; 2010 Nov; 26(9):e330-5. PubMed ID: 21076724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Symptomatic coronary heart disease. Impressive plaque reduction with high dose statins].
    Einecke D
    MMW Fortschr Med; 2011 Dec; 153(49-50):18. PubMed ID: 22308585
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of rosuvastatin versus atorvastatin on small dense low-density lipoprotein: a meta-analysis of randomized trials.
    Takagi H; Niwa M; Mizuno Y; Yamamoto H; Goto SN; Umemoto T
    Heart Vessels; 2014 May; 29(3):287-99. PubMed ID: 23644555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Randomized head-to-head comparison of pitavastatin, atorvastatin, and rosuvastatin for safety and efficacy (quantity and quality of LDL): -- the PATROL trial].
    Saku K; Zhang B; Noda K
    Nihon Naika Gakkai Zasshi; 2011 Dec; 100(12):3679-86. PubMed ID: 22338904
    [No Abstract]   [Full Text] [Related]  

  • 20. Atorvastatin improves tubular status in non-diabetic patients with chronic kidney disease - placebo controlled, randomized, cross-over study.
    Renke M; Tylicki L; Rutkowski P; Neuwelt A; Larczyński W; Ziętkiewicz M; Aleksandrowicz E; Lysiak-Szydłowska W; Rutkowski B
    Acta Biochim Pol; 2010; 57(4):547-52. PubMed ID: 21079818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.